234 related articles for article (PubMed ID: 17878286)
21. The role of C/EBPdelta in the early stages of adipogenesis.
Hishida T; Nishizuka M; Osada S; Imagawa M
Biochimie; 2009 May; 91(5):654-7. PubMed ID: 19233245
[TBL] [Abstract][Full Text] [Related]
22. Modulation of peroxisome proliferator-activated receptor delta and gamma transcripts in swine endometrial tissue during early gestation.
Lord E; Murphy BD; Desmarais JA; Ledoux S; Beaudry D; Palin MF
Reproduction; 2006 May; 131(5):929-42. PubMed ID: 16672357
[TBL] [Abstract][Full Text] [Related]
23. Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation.
Hu Y; Davies GE
Phytomedicine; 2009 Sep; 16(9):864-73. PubMed ID: 19403287
[TBL] [Abstract][Full Text] [Related]
24. Identification of novel PPARgamma target genes by integrated analysis of ChIP-on-chip and microarray expression data during adipocyte differentiation.
Nakachi Y; Yagi K; Nikaido I; Bono H; Tonouchi M; Schönbach C; Okazaki Y
Biochem Biophys Res Commun; 2008 Jul; 372(2):362-6. PubMed ID: 18489901
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome-proliferator-activated receptor delta mediates the effects of long-chain fatty acids on post-confluent cell proliferation.
Jehl-Pietri C; Bastie C; Gillot I; Luquet S; Grimaldi PA
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):93-8. PubMed ID: 10926831
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-beta1 is a molecular target for the peroxisome proliferator-activated receptor delta.
Kim HJ; Ham SA; Kim SU; Hwang JY; Kim JH; Chang KC; Yabe-Nishimura C; Kim JH; Seo HG
Circ Res; 2008 Feb; 102(2):193-200. PubMed ID: 18007025
[TBL] [Abstract][Full Text] [Related]
27. Roles of peroxisome proliferator-activated receptors delta and gamma in myoblast transdifferentiation.
Holst D; Luquet S; Kristiansen K; Grimaldi PA
Exp Cell Res; 2003 Aug; 288(1):168-76. PubMed ID: 12878168
[TBL] [Abstract][Full Text] [Related]
28. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
29. Norepinephrine and rosiglitazone synergistically induce Elovl3 expression in brown adipocytes.
Jörgensen JA; Zadravec D; Jacobsson A
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1159-68. PubMed ID: 17726147
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotective efficacy of the peroxisome proliferator-activated receptor delta-selective agonists in vitro and in vivo.
Iwashita A; Muramatsu Y; Yamazaki T; Muramoto M; Kita Y; Yamazaki S; Mihara K; Moriguchi A; Matsuoka N
J Pharmacol Exp Ther; 2007 Mar; 320(3):1087-96. PubMed ID: 17167170
[TBL] [Abstract][Full Text] [Related]
31. Progeny from dedifferentiated bovine adipocytes display protracted adipogenesis.
Fernyhough ME; Hausman GJ; Dodson MV
Cells Tissues Organs; 2008; 188(4):359-72. PubMed ID: 18493114
[TBL] [Abstract][Full Text] [Related]
32. Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy.
Keil S; Matter H; Schönafinger K; Glien M; Mathieu M; Marquette JP; Michot N; Haag-Diergarten S; Urmann M; Wendler W
ChemMedChem; 2011 Apr; 6(4):633-53. PubMed ID: 21400663
[TBL] [Abstract][Full Text] [Related]
33. The PPARgamma coding region and its role in visceral obesity.
Boon Yin K; Najimudin N; Muhammad TS
Biochem Biophys Res Commun; 2008 Jun; 371(2):177-9. PubMed ID: 18413145
[TBL] [Abstract][Full Text] [Related]
34. Activation of PPARγ2 by PPARγ1 through a functional PPRE in transdifferentiation of myoblasts to adipocytes induced by EPA.
Luo H; Zhou Y; Hu X; Peng X; Wei H; Peng J; Jiang S
Cell Cycle; 2015; 14(12):1830-41. PubMed ID: 25892270
[TBL] [Abstract][Full Text] [Related]
35. Carbacyclin induces carnitine palmitoyltransferase-1 in cardiomyocytes via peroxisome proliferator-activated receptor (PPAR) delta independent of the IP receptor signaling pathway.
Kuroda T; Hirota H; Fujio Y; Sugiyama S; Masaki M; Hiramoto Y; Shioyama W; Okamoto K; Hori M; Yamauchi-Takihara K
J Mol Cell Cardiol; 2007 Jul; 43(1):54-62. PubMed ID: 17540403
[TBL] [Abstract][Full Text] [Related]
36. Peroxisome proliferator-activated receptor gamma and the regulation of adipocyte function: lessons from human genetic studies.
Gurnell M
Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):501-23. PubMed ID: 16311214
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel PPARgamma target genes in primary human adipocytes.
Perera RJ; Marcusson EG; Koo S; Kang X; Kim Y; White N; Dean NM
Gene; 2006 Mar; 369():90-9. PubMed ID: 16380219
[TBL] [Abstract][Full Text] [Related]
38. Fat-specific FUS-DDIT3-transgenic mice establish PPARgamma inactivation is required to liposarcoma development.
Pérez-Mancera PA; Vicente-Dueñas C; González-Herrero I; Sánchez-Martín M; Flores-Corral T; Sánchez-García I
Carcinogenesis; 2007 Oct; 28(10):2069-73. PubMed ID: 17468515
[TBL] [Abstract][Full Text] [Related]
39. AMP-activated protein kinase and adipogenesis in sheep fetal skeletal muscle and 3T3-L1 cells.
Tong J; Zhu MJ; Underwood KR; Hess BW; Ford SP; Du M
J Anim Sci; 2008 Jun; 86(6):1296-305. PubMed ID: 18344293
[TBL] [Abstract][Full Text] [Related]
40. High-glucose-induced prostaglandin E(2) and peroxisome proliferator-activated receptor delta promote mouse embryonic stem cell proliferation.
Kim YH; Han HJ
Stem Cells; 2008 Mar; 26(3):745-55. PubMed ID: 18096720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
